HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

R Suzanne Zukin Selected Research

R- alpha- amino- 5- chloro- 1- (phosphonomethyl)- 1H- benzimidazole- 2- propanoic acid hydrochloride

8/2004Characterization of two novel N-methyl-D-aspartate antagonists: EAA-090 (2-[8,9-dioxo-2,6-diazabicyclo [5.2.0]non-1(7)-en2-yl]ethylphosphonic acid) and EAB-318 (R-alpha-amino-5-chloro-1-(phosphonomethyl)-1H-benzimidazole-2-propanoic acid hydrochloride).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


R Suzanne Zukin Research Topics

Disease

30Ischemia
02/2019 - 02/2002
5Fragile X Syndrome (Martin Bell Syndrome)
01/2016 - 01/2010
5Brain Ischemia (Cerebral Ischemia)
02/2012 - 03/2005
4Cognitive Dysfunction
01/2015 - 03/2007
3Ischemic Stroke
01/2013 - 06/2010
2Autistic Disorder (Autism)
10/2015 - 12/2010
2Rett Syndrome (Rett's Disorder)
10/2015 - 02/2008
2Neoplasms (Cancer)
04/2012 - 02/2012
2Heart Arrest (Cardiac Arrest)
07/2009 - 03/2002
2Stroke (Strokes)
07/2009 - 05/2009
1AIDS-Related Complex (ARC)
10/2018
1Neurofibromatosis 1 (Neurofibromatosis Type I)
10/2015
1Tuberous Sclerosis (Bourneville's Disease)
10/2015
1Epilepsy (Aura)
01/2013
1Heart Diseases (Heart Disease)
04/2012
1Intellectual Disability (Idiocy)
12/2010
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2009
1Mood Disorders (Mood Disorder)
02/2008
1Huntington Disease (Huntington's Disease)
02/2008
1Parkinson Disease (Parkinson's Disease)
02/2008
1Mental Disorders (Mental Disorder)
02/2008
1Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi)
02/2008
1Hyperthermia
06/2007
1Brain Injuries (Brain Injury)
12/2006
1Wounds and Injuries (Trauma)
12/2006
1Memory Disorders (Memory Loss)
02/2006
1Weight Gain
07/2005
1Lordosis
07/2005

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
10/2018 - 02/2002
11Estradiol (Delestrogen)FDA LinkGeneric
09/2015 - 07/2005
8Estrogens (Estrogen)FDA Link
07/2013 - 03/2002
7Hormones (Hormone)IBA
09/2015 - 03/2002
7Messenger RNA (mRNA)IBA
07/2013 - 02/2002
5CaspasesIBA
09/2012 - 03/2004
5AMPA Receptors (AMPA Receptor)IBA
04/2012 - 03/2003
4Caspase 3 (Caspase-3)IBA
03/2010 - 03/2002
3Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
01/2015 - 01/2010
3Estrogen ReceptorsIBA
01/2010 - 03/2007
2salicylhydroxamic acid (SHAM)IBA
02/2019 - 12/2006
2LithiumIBA
01/2015 - 03/2011
2Histones (Histone)IBA
10/2014 - 03/2007
2RE1-silencing transcription factorIBA
04/2012 - 03/2007
2Neuroprotective AgentsIBA
01/2012 - 01/2010
2Glycogen Synthase Kinase 3 betaIBA
03/2010 - 05/2009
2Carrier Proteins (Binding Protein)IBA
03/2008 - 03/2004
2Transcription Factors (Transcription Factor)IBA
03/2007 - 03/2007
2CalciumIBA
08/2005 - 11/2004
2alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
08/2005 - 08/2004
2AMPA 2 glutamate receptor ionotropicIBA
03/2003 - 03/2002
1activity regulated cytoskeletal-associated proteinIBA
10/2018
1postsynaptic density proteinsIBA
10/2018
1Fragile X Mental Retardation ProteinIBA
10/2018
1Pharmaceutical PreparationsIBA
01/2016
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2015
1TensinsIBA
10/2015
1Biological ProductsIBA
10/2015
1TOR Serine-Threonine KinasesIBA
10/2015
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
09/2015
1IGF Type 1 Receptor (IGF 1 Receptor)IBA
09/2015
1Lysine (L-Lysine)FDA Link
10/2014
1pyrvinium (Vankin)FDA Link
04/2014
1Casein Kinase I (Casein Kinase 1)IBA
04/2014
1SurvivinIBA
07/2013
1ChromatinIBA
01/2013
1ABT-737IBA
02/2012
1Estradiol Congeners (Synthetic Estrogens)IBA
08/2011
1metabotropic glutamate receptor type 1IBA
12/2010
1Glycogen Synthase (Synthase I)IBA
03/2010
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
03/2010
1DNA (Deoxyribonucleic Acid)IBA
02/2010
1Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
02/2010
1EndonucleasesIBA
02/2010
1Gonadal Steroid Hormones (Sex Hormones)IBA
07/2009
1Phosphotransferases (Kinase)IBA
05/2009
1cyclic 3',5'-thymidine monophosphate (cTMP)IBA
05/2009
1Cytochromes c (Cytochrome c)IBA
03/2008
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
03/2008
1Histone Deacetylase InhibitorsIBA
02/2008
1Naloxone (Narcan)FDA LinkGeneric
03/2007
1ElementsIBA
03/2007
1OligodeoxyribonucleotidesIBA
03/2007
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
03/2007
1Insulin-Like Growth Factor I (IGF-1)IBA
03/2007
1Chelating AgentsIBA
06/2006
1ethylenediamine (ethylenediamine dihydroiodide)FDA Link
06/2006
1Oxygen (Dioxygen)IBA
05/2006
1Glucose (Dextrose)FDA LinkGeneric
05/2006
11-naphthylacetylspermineIBA
08/2005
1Estrogen Receptor alphaIBA
07/2005
1Fulvestrant (Faslodex)FDA Link
07/2005
1Estrogen Receptor betaIBA
07/2005
1WAY 200070IBA
07/2005
1Calcium Chelating AgentsIBA
11/2004
1Glutamate Receptors (Glutamate Receptor)IBA
11/2004
1Edetic Acid (EDTA)FDA Link
11/2004
1Kainic Acid (Kainate)IBA
08/2004
1R- alpha- amino- 5- chloro- 1- (phosphonomethyl)- 1H- benzimidazole- 2- propanoic acid hydrochlorideIBA
08/2004

Therapy/Procedure

1Ovariectomy (Oophorectomy)
01/2010
1Therapeutics
03/2007
1Intraventricular Injections
11/2004